Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079830 | SCV000111713 | benign | not specified | 2014-10-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000079830 | SCV000308237 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000079830 | SCV000512726 | benign | not specified | 2016-01-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001664302 | SCV001876728 | benign | Bethlem myopathy 1A | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001664303 | SCV001876739 | benign | Ullrich congenital muscular dystrophy 1A | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001664302 | SCV002405791 | benign | Bethlem myopathy 1A | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004713222 | SCV005276038 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000079830 | SCV001741380 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000079830 | SCV001922847 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000079830 | SCV001956924 | benign | not specified | no assertion criteria provided | clinical testing |